Form 8-K - Current report:
SEC Accession No. 0001193125-22-005120
Filing Date
2022-01-10
Accepted
2022-01-10 08:10:55
Documents
13
Period of Report
2022-01-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d289427d8k.htm   iXBRL 8-K 31491
2 EX-99.1 d289427dex991.htm EX-99.1 19083
  Complete submission text file 0001193125-22-005120.txt   186327

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sldb-20220110.xsd EX-101.SCH 2891
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sldb-20220110_lab.xml EX-101.LAB 18887
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sldb-20220110_pre.xml EX-101.PRE 11859
7 EXTRACTED XBRL INSTANCE DOCUMENT d289427d8k_htm.xml XML 3475
Mailing Address 141 PORTLAND STREET, FIFTH FLOOR CAMBRIDGE MA 02139
Business Address 141 PORTLAND STREET, FIFTH FLOOR CAMBRIDGE MA 02139 617-337-4680
Solid Biosciences Inc. (Filer) CIK: 0001707502 (see all company filings)

EIN.: 900943402 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38360 | Film No.: 22519784
SIC: 2836 Biological Products, (No Diagnostic Substances)